I've got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.
The Journal of Clinical Investigation
|November 15, 2016
Summary
Researchers identified 25,270 self-peptides presented by HLA molecules, crucial for understanding CD8+ T cell responses in cancer and autoimmunity. This work provides a predictive tool for identifying disease-relevant antigens.
Area of Science:
- Immunology
- Proteomics
- Bioinformatics
Background:
- CD8+ T cells are vital for fighting infections and are implicated in cancer and autoimmune diseases.
- Clinical manipulation of CD8+ T cells is hindered by a lack of knowledge regarding self-peptide targets.
Purpose of the Study:
- To identify and characterize MHC class I-associated peptides presented by various HLA A and B allomorphs.
- To develop a predictive algorithm for identifying disease-relevant self-peptides.
Main Methods:
- Mass spectrometry was used to identify 25,270 MHC class I-associated peptides from 18 B cell lines.
- Extensive bioinformatic analysis was performed to analyze peptide generation and develop a predictive algorithm.
Main Results:
- A comprehensive catalog of 25,270 MHC class I-associated peptides was generated.
- Surprising insights into the selective nature of peptide generation were revealed.
- A predictive algorithm for disease-relevant self-peptides was created.
Conclusions:
- The findings provide a valuable resource for understanding CD8+ T cell recognition in health and disease.
- The predictive algorithm is expected to accelerate research in cancer immunotherapy and autoimmunity.
More Related Videos
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
8.5K
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.6K
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
